|
Volumn 14, Issue 1, 2004, Pages 55-64
|
Poly(ADP-ribose) polymerase inhibitors counteract diabetes- and hypoxia-induced retinal vascular endothelial growth factor overexpression.
a a a a a a a a |
Author keywords
[No Author keywords available]
|
Indexed keywords
1,5 ISOQUINOLINEDIOL;
1,5-ISOQUINOLINEDIOL;
3 AMINOBENZAMIDE;
3-AMINOBENZAMIDE;
BENZAMIDE DERIVATIVE;
ENZYME INHIBITOR;
MESSENGER RNA;
NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE;
NUCLEIC ACID SYNTHESIS INHIBITOR;
QUINOLINE DERIVATIVE;
SORBITOL;
VASCULOTROPIN;
ANIMAL;
ARTICLE;
CELL HYPOXIA;
CHEMISTRY;
DIABETIC RETINOPATHY;
DRUG ANTAGONISM;
DRUG EFFECT;
ENZYMOLOGY;
EXPERIMENTAL DIABETES MELLITUS;
GENETICS;
HUMAN;
IMMUNOCHEMISTRY;
METABOLISM;
OXIDATIVE STRESS;
PIGMENT EPITHELIUM;
RAT;
RETINA;
UPREGULATION;
WISTAR RAT;
ANIMALS;
BENZAMIDES;
CELL HYPOXIA;
DIABETES MELLITUS, EXPERIMENTAL;
DIABETIC RETINOPATHY;
ENZYME INHIBITORS;
HUMANS;
IMMUNOCHEMISTRY;
NUCLEIC ACID SYNTHESIS INHIBITORS;
OXIDATIVE STRESS;
PIGMENT EPITHELIUM OF EYE;
POLY(ADP-RIBOSE) POLYMERASES;
QUINOLINES;
RATS;
RATS, WISTAR;
RETINA;
RNA, MESSENGER;
SORBITOL;
UP-REGULATION;
VASCULAR ENDOTHELIAL GROWTH FACTORS;
|
EID: 12144254266
PISSN: 11073756
EISSN: None
Source Type: Journal
DOI: 10.3892/ijmm.14.1.55 Document Type: Article |
Times cited : (66)
|
References (0)
|